Chunghwa Chemical Synthesis & Biotech Co., LtdFDA
- FEI
- 3002806677
- Record date
- Establishment
- Active Pharmaceutical Ingredient Manufacturer
- Location
- Taiwan
Every published Form FDA 483 issued in November 2022, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
6
Published 483s in November 2022
6
Distinct firms
| Company | FEI | Establishment type | Location | FDA date | Source |
|---|---|---|---|---|---|
| Chunghwa Chemical Synthesis & Biotech Co., Ltd | 3002806677 | Active Pharmaceutical Ingredient Manufacturer | Taiwan | FDA | |
| Fuji Yakuhin Co., Ltd. | 3008538640 | Finished Pharmaceutical Manufacturer | Japan | FDA | |
| CareFirst Specialty Pharmacy LLC | 3012258924 | Producer of Non Sterile Drug Products | New Jersey, United States | FDA | |
| Pharmacy Innovations | 3004858203 | Producer of Sterile Drug Products | Pennsylvania, United States | FDA | |
| Lupin Limited | 3002807511 | Finished Pharmaceutical Manufacturer | India | FDA | |
| Apitoria Pharma Private Limited | 3006370489 | Drug Substance Intermediate Manufacturer | India | FDA |